-
Product Insights
Likelihood of Approval Analysis for Polycystic Kidney Disease
Overview How likely is it that the drugs in Polycystic Kidney Disease will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Polycystic Kidney Disease Overview Polycystic kidney disease (PKD) is a disorder...
-
Product Insights
Likelihood of Approval Analysis for Cervical Intraepithelial Neoplasia (CIN)
Overview How likely is it that the drugs in Cervical Intraepithelial Neoplasia (CIN) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Cervical Intraepithelial Neoplasia (CIN) Overview Cervical intraepithelial neoplasia (CIN), also...
-
Product Insights
Likelihood of Approval Analysis for Paroxysmal Nocturnal Hemoglobinuria
Overview How likely is it that the drugs in Paroxysmal Nocturnal Hemoglobinuria will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Paroxysmal Nocturnal Hemoglobinuria Overview Paroxysmal nocturnal hemoglobinuria is a rare disease...
-
Product Insights
Likelihood of Approval Analysis for Pancreatic Tumor
Overview How likely is it that the drugs in Pancreatic Tumor will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Pancreatic Tumor Overview Pancreatic cancer refers to the carcinoma arising from the...
-
Product Insights
Likelihood of Approval Analysis for Post-Essential Thrombocythemia Myelofibrosis (Post-ET MF)
Overview How likely is it that the drugs in Post-Essential Thrombocythemia Myelofibrosis (Post-ET MF) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Post-Essential Thrombocythemia Myelofibrosis (Post-ET MF) Overview Post-essential thrombocythemia myelofibrosis...
-
Product Insights
Likelihood of Approval Analysis for Pyelonephritis
Overview How likely is it that the drugs in Pyelonephritis will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Pyelonephritis Overview Pyelonephritis is a specific type of urinary tract infection (UTI) that...
-
Product Insights
Likelihood of Approval Analysis for Malignant Pleural Mesothelioma
Overview How likely is it that the drugs in Malignant Pleural Mesothelioma will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Malignant Pleural Mesothelioma Overview Malignant pleural mesothelioma is a rare cancer...
-
Product Insights
Likelihood of Approval Analysis for Neisseria Infections
Overview How likely is it that the drugs in Neisseria Infections will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Neisseria Infections Overview Meningococcal disease refers to any illness caused by bacteria...
-
Product Insights
Likelihood of Approval Analysis for Ankylosing Spondylitis (Bekhterev’s Disease)
Overview How likely is it that the drugs in Ankylosing Spondylitis (Bekhterev's Disease) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Ankylosing Spondylitis (Bekhterev's Disease) Overview Ankylosing spondylitis is a type...
-
Product Insights
Likelihood of Approval Analysis for Osteoporosis
Overview How likely is it that the drugs in Osteoporosis will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Osteoporosis Overview Osteoporosis, or thinning bones, makes bones weak and more likely to...